NCT03411252View on ClinicalTrials.gov

Mirabegron in Achalasia: A Clinical and Manometric Proof of Concept Pilot Study

EARLY_PHASE1TerminatedINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

February 15, 2018

Primary Completion Date

December 15, 2019

Study Completion Date

December 15, 2019

Conditions

Achalasia

Interventions

DRUG

Mirabegron 50 MG

Myrbetriq (Mirabegron) tablet

DRUG

Placebo

Sugar pill manufactured to mimic Mirabegron

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

Sponsors

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

Thomas Jefferson University

OTHER